Progressive Increases in Bone Mass and Bone Strength in an Ovariectomized Rat Model of Osteoporosis After 26 Weeks of Treatment With a Sclerostin Antibody-Reference-Cited by-同舟云学术

Progressive Increases in Bone Mass and Bone Strength in an Ovariectomized Rat Model of Osteoporosis After 26 Weeks of Treatment With a Sclerostin Antibody

Published:2014-12-01 Issue:12 Volume:155 Page:4785-4797
ISSN:0013-7227
Container-title:Endocrinology
language:en
Short-container-title:

Author:

Li Xiaodong¹,Niu Qing-Tian¹,Warmington Kelly S.¹,Asuncion Franklin J.¹,Dwyer Denise¹,Grisanti Mario¹,Han Chun-Ya¹,Stolina Marina¹,Eschenberg Michael J.²,Kostenuik Paul J.¹,Simonet William S.¹,Ominsky Michael S.¹,Ke Hua Zhu¹

Affiliation:

1. Departments of Metabolic Disorders (X.L., Q.-T.N., K.S.W., F.J.A., D.D., M.G., C.-Y.H., M.S., P.J.K., W.S.S., M.S.O., H.Z.K.), Amgen Inc, Thousand Oaks, California 91320

2. Biostatistics (M.J.E.), Amgen Inc, Thousand Oaks, California 91320

Publisher

The Endocrine Society

Subject

Endocrinology

Link

http://academic.oup.com/endo/article-pdf/155/12/4785/10828029/endo4785.pdf

Reference32 articles.

1. The clinical features of sclerosteosis. A review of the manifestations in twenty-five affected individuals;Beighton;Ann Intern Med,1976

2. The radiology of sclerosteosis;Beighton;Br J Radiol,1976

3. Sclerosteosis;Beighton;J Med Genet,1988

4. The natural history of sclerosteosis;Hamersma;Clin Genet,2003